Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07805408
What this trial is testing

A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 3,714
Not applicableUnknownNCT04214951
What this trial is testing

Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06929299
What this trial is testing

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd. 56
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69
Testing effectiveness (Phase 2)Study completedNCT03102593
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
argenx 38
Not applicableLooking for participantsNCT06479291
What this trial is testing

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

Who this might be right for
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng 126
Early research (Phase 1)Study completedNCT06148389
What this trial is testing

The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

Who this might be right for
Primary Immune Thrombocytopenia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 36
Large-scale testing (Phase 3)Looking for participantsNCT06544499
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx 69
Not applicableStudy completedNCT02063763
What this trial is testing

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Who this might be right for
Adult PatientsImmune Primary ThrombocytopeniaSplenectomy+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 31
Large-scale testing (Phase 3)Study completedNCT01734044
What this trial is testing

RhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University 158
Large-scale testing (Phase 3)Study completedNCT00657410
What this trial is testing

Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura

Who this might be right for
Nonneoplastic Condition
Gruppo Italiano Malattie EMatologiche dell'Adulto 150
Large-scale testing (Phase 3)Study completedNCT01349790
What this trial is testing

Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia

Who this might be right for
Primary Thrombocytopenia
Octapharma 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660172
What this trial is testing

Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 36
Not applicableLooking for participantsNCT04890041
What this trial is testing

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

Who this might be right for
Primary Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Very early researchLooking for participantsNCT06519565
What this trial is testing

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Testing effectiveness (Phase 2)UnknownNCT05124028
What this trial is testing

Orelabrutinib in Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06776510
What this trial is testing

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07278908
What this trial is testing

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 248
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Next Page